MediShield Life coverage will be reviewed to possibly include new treatments involving cell, tissue and gene therapy products. SINGAPORE: The MediShield Life insurance plan is being reviewed to ensure healthcare remains accessible and affordable amid rising costs, Health Minister Ong Ye Kung announced on Wednesday .
As a result, the proportion of subsidised bills adequately covered by MediShield Life has come down to around eight out of 10 and this is expected to continue to slip further, said Mr Ong. Singapore to build new hospital in Tengah, expand home care initiatives to meet ageing population needs However, while the technology is promising and advancing fast, it is nascent and very expensive, he added."It could cost anything from a few hundred thousand dollars to a few million dollars, per treatment."
“The last time we reviewed the scheme, premiums went up by 25 per cent on average,” Mr Ong pointed out. To support care continuity between acute and community hospitals, MOH will expand subsidy coverage to more diagnostic services and drugs at the latter.